Positive EU opinion for Sanofi Pasteur's intradermal flu vaccine microinjection
This article was originally published in Scrip
Executive Summary
The first intradermal microinjected seasonal influenza vaccine, Sanofi Pasteur MSD's Intanza/IDflu, has been recommended for approval by the EU'sCHMP. It was developed in collaboration with BD(Becton, Dickinson).